Pharmacovigilance – Products
Product News
New Cell & Gene Therapy Solutions From Form Bio Analyze Billions of Potential Construct Candidates
Form Bio, announced capabilities for cell and gene therapy companies to rapidly model billions of potential construct candidates.
Product News
Kuano Raises £1.8M in Seed Funding to Accelerate Quantum Drug Discovery
Kuano, announced the close of its £1.8M seed funding round. The investment will facilitate further validation of Kuano’s quantum simulation platform for the design of more effective drug candidates targeting enzymes.
Product News
Novartis Kisqali® Reduced the Risk of Cancer Recurrence While Maintaining Quality of Life
Novartis presents new patient-reported outcomes (PRO) data from the Phase III NATALEE trial at the European Society for Medical Oncology (ESMO) Virtual Plenary.
Whitepaper
Antibody–Drug Conjugates: A Novel Paradigm for Cancer Therapy
This whitepaper highlights the key molecular components of ADCs and the challenges and opportunities for their future development.
Product
Advertisement
Influenza Vaccine Development and Production Solutions
Learn more about influenza vaccine solutions!
Product News
Lab-on-Chip Technology for Screening Live Tumor
ScreenIn3D reports on how their proprietary lab-on-a-chip technology is enabling cancer researchers to miniaturize their testing of biopsy tissue samples across a wide range of modalities and to test both single and combination drug therapies.
Product News
RemeGen's Telitacicept Shows Significant Promise in Phase II Trial for Primary Sjogren's Syndrome
RemeGen Co., Ltd. announced that their Phase II clinical study of telitacicept for the treatment of Primary Sjögren's Syndromein adults has been published.
Product News
Sapient’s High Complexity CLIA Laboratory Receives Accreditation From the College of American Pathologists
Sapient has been awarded accreditation from the College of American Pathologists (CAP).
Product News
InSphero AG and Cosmo Bio Co., Ltd Enter Into Strategic Partnership
InSphero AG and Cosmo Bio Co., Ltd. are announcing a strategic partnership to distribute InSphero’s innovative product portfolio in Japan.
Product News
Tillotts Pharma and TVM Capital Life Science Announce Formation of Mage Biologics to Develop Innovative Oral Antibody Therapy for Ulcerative Colitis
TVM Capital Life Science, together with specialty pharma company, Tillotts Pharma has announced that the companies will jointly invest up to USD 28 million in the newly formed U.S.-based biotechnology company, Mage Biologics Inc.
Advertisement